Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.90x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.18x
$28.02Latest market snapshot
Implied fair value · at BOX's multiple
$139.55398.0% above market
2.30 ACAD EPS (TTM)×60.67x BOX P/E=$139.55
Market $28.02Implied $139.55
BOX · current priceP/E 60.67x
$35.19Latest market snapshot
Implied fair value · at ACAD's multiple
$7.0779.9% below market
0.58 BOX EPS (TTM)×12.18x ACAD P/E=$7.07
Market $35.19Implied $7.07